Related Experiment Video
Updated: May 16, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Cellular alchemy and the golden age of reprogramming
1Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, MA 02115, USA. george.daley@childrens.harvard.edu
Cell
|December 11, 2012
Summary
The 2012 Nobel Prize in Physiology or Medicine honored discoveries enabling the reprogramming of cells. Scientists demonstrated that mature cells can be reverted to a pluripotent state, challenging established biological concepts.
Area of Science:
- Developmental biology
- Cellular reprogramming
- Stem cell research
Background:
- The 2012 Nobel Prize in Physiology or Medicine recognized groundbreaking work in cellular reprogramming.
- John Gurdon and Shinya Yamanaka independently made pivotal discoveries regarding cell plasticity.
Discussion:
- Gurdon's work in the 1960s showed that differentiated cells retain pluripotency.
- Yamanaka's research in the 2000s identified key factors to induce pluripotency in mature cells, creating induced pluripotent stem cells (iPSCs).
Key Insights:
- Established the concept that cell identity is not fixed and can be reversed.
- Demonstrated the feasibility of reawakening inherent pluripotency in somatic cells.
- Revolutionized understanding of cellular identity and developmental potential.
Outlook:
- Opened new avenues for regenerative medicine and disease modeling.
- Provided foundational knowledge for stem cell therapies.
- Continues to influence research in epigenetics and cell fate determination.
More Related Videos
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:14Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
01:23Cellular Adaptation I: Introduction and Atrophy
Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...